Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PHACE (Posterior Fossa Brain Malformations, Hemangiomas, Arterial Anomalies, Cardiac Defects, and Eye Abnormalities) Syndrome in a Newborn With Bilateral Ocular Hemangiomas: The Importance of Early Recognition and Multidisciplinary Management.

Cureus·2026
Same author

Examining implementation strategies to reduce disparities in lung cancer screening uptake by state Medicaid expansion status: a scoping review.

Preventive oncology & epidemiology·2026
Same author

Sustainability through funding and leadership: a mixed-methods study of tobacco treatment programs across U.S. National Cancer Institute-designated Cancer Centers.

Implementation science communications·2026
Same author

Dual-Root Repair of Concomitant Medial and Lateral Meniscal Root Tears Improves Patient-Reported Outcomes Whereas Isolated Single-Root Repair or No Repair Does Not.

Arthroscopy, sports medicine, and rehabilitation·2026
Same author

Reducing Length of Stay for Pediatric and Adult Patients in a Student-Run Free Clinic: A Quality Improvement Initiative.

Cureus·2025
Same author

Organizational readiness for implementing clinical decision support tools in chronic pain care: a mixed methods evaluation.

Frontiers in health services·2025

Related Experiment Video

Updated: Jun 27, 2026

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

Decreasing Herpes Simplex Virus (HSV) Testing Turnaround Time for Infants in a Hospital Setting: A Continuous Quality

Miranda J Reid, Peter S Chang, Stacey G Beal

    Joint Commission Journal on Quality and Patient Safety
    |June 25, 2026
    PubMed
    Summary

    Increasing herpes simplex virus (HSV) lab processing frequency significantly reduced test turnaround times (TAT) and length of stay (LOS) for febrile infants. This improvement in HSV diagnostics also led to a decrease in hospitalization costs.

    More Related Videos

    Plaquing of Herpes Simplex Viruses
    04:41

    Plaquing of Herpes Simplex Viruses

    Published on: November 5, 2021

    Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
    11:28

    Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus

    Published on: October 7, 2011

    Related Experiment Videos

    Last Updated: Jun 27, 2026

    Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
    06:14

    Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

    Published on: May 13, 2021

    Plaquing of Herpes Simplex Viruses
    04:41

    Plaquing of Herpes Simplex Viruses

    Published on: November 5, 2021

    Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus
    11:28

    Dissecting Host-virus Interaction in Lytic Replication of a Model Herpesvirus

    Published on: October 7, 2011

    Area of Science:

    • Medical Diagnostics
    • Infectious Disease Management
    • Healthcare Operations

    Background:

    • Febrile infants often require hospitalization and antiviral treatment pending herpes simplex virus (HSV) diagnosis.
    • Current diagnostic processes can lead to prolonged hospital stays and increased costs.

    Purpose of the Study:

    • To decrease length of stay (LOS), direct hospitalization costs, and lab turnaround time (TAT) for febrile infants by increasing HSV lab processing frequency.

    Main Methods:

    • Three Plan-Do-Study-Act (PDSA) cycles were implemented to incrementally increase HSV testing frequency.
    • Data on patient LOS, TAT, and direct care costs were extracted from electronic medical records.
    • Statistical analysis using Kruskal-Wallis and Dunn Tests compared outcomes between PDSA cycles.

    Main Results:

    • Turnaround time (TAT) for HSV testing decreased significantly, from over 30 hours to under 6 hours.
    • Median length of stay (LOS) for febrile infants reduced from 2.4 to 1.9 days.
    • Direct care costs saw a moderate decrease, from $4,348 to $4,164.

    Conclusions:

    • Increased HSV lab processing frequency effectively reduces TAT and LOS in febrile infants.
    • While cost reductions were moderate, the improvements in diagnostic efficiency enhance patient care.
    • Collaborative efforts between pediatric and pathology departments can optimize care for febrile infants nationwide.